Dogwood Therapeutics Expands Pipeline with Worldwide, Royalty-Free SP16 License—NCI-Funded Trial on Horizon
Market Chameleon (Mon, 29-Sep 9:54 AM)
Dogwood Therapeutics Expands Cancer Pain Pipeline with Exclusive Global SP16 License in All-Stock Deal
Market Chameleon (Mon, 29-Sep 7:37 AM)
